Physician
Golby, Angela
Golby, Angela was paid $179K by Medicaid between Feb 2018 and Aug 2024, across 6 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 55% of everything it billed.
33Billing provider infoGOLBY, ANGELA
MORTON, IL 61550
MORTON, IL 61550
33aNPI1639183536assigned 07/28/2006
33bProvider typeFamily Medicine Physician
28Total paid$179K
24GClaims3,454
24DCodes billed6
24AFirst – last monthFeb 2018 – Aug 2024
Compared with peers
Next to other Family Medicine Physician providers in Illinois
Rank by total paid#624 of 2,947
Median peer was paid$43K
This provider vs. median4.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 44 | $2K | |
| 2019 | 131 | $8K | |
| 2020 | 810 | $52K | |
| 2021 | 710 | $39K | |
| 2022 | 434 | $23K | |
| 2023 | 813 | $33K | |
| 2024incomplete | 512 | $22K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 55% | 2,023 | 1,853 | $98K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 41% | 1,011 | 830 | $74K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.9% | 336 | 296 | $5K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 15 | 14 | $984.97 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 56 | 56 | $721.28 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 13 | 13 | $600.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.